Enzymatic activation of chemicals to toxic metabolites.

A variety of enzymes function in the oxygenation, oxidation-reduction, conjugation, and hydrolysis of drugs and other foreign chemicals. Often these enzymes detoxicate chemicals to prevent detrimental effects. In this review we will, however, concentrate on cases in which metabolism activates chemicals to reactive species which cause cellular damage. Particular attention will be given to mixed-function oxidases, which carry out a variety of oxygenations, as well as other reactions. (We will focus on cellular toxicity as opposed to initiation of tumorigenesis in this review.) In many cases, considerable circumstantial evidence exists linking these enzymes to enhanced toxicity of chemicals, although causal relationships have seldom been demonstrated. Further, in very few cases is the explicit cause of toxicity known. Modification of critical protein residues is suspected, although oxidative stress may also be involved in some cases. We discuss general aspects of mechanisms of toxic action, briefly list all cases in which metabolism is suspected to play a role in enhancing toxicity, and review a few examples in detail where substantial chemical and enzymatic information is available. The latter instances would involve knowledge of the enzymes involved, chemical evidence on the structures of the reactive metabolites, identification of adducts, and some inference into the biological processes which are effected to elicit toxicity. We consider, in this regard, vinyl halides (which have been a focus in our own laboratory), acetaminophen, pyrrolizidine alkaloids, and fluoroxene.

[1]  T. Kamataki,et al.  Cytochrome P-450 as a determinant of sex difference of drug metabolism in the rat. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[2]  L. Marnett,et al.  Co-oxygenation of organic substrates by the prostaglandin synthetase of sheep vesicular gland. , 1975, The Journal of biological chemistry.

[3]  L. T. Burka,et al.  Enzymatic mono oxygenation of halogen atoms cytochrome p 450 catalyzed oxidation of iodo benzene by iodoso benzene , 1980 .

[4]  Suicide enzyme inactivators , 1976 .

[5]  H. Gelboin Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[6]  D. Jerina,et al.  Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice. , 1978, Cancer research.

[7]  R. Jaeger,et al.  1,1-Dichloroethylene hepatotoxicity: Proposed mechanism of action and distribution and binding of 14C radioactivity following inhalation exposure in rats , 1977, Environmental health perspectives.

[8]  H. Greim,et al.  Mutagenicity in vitro and potential carcinogenicity of chlorinated ethylenes as a function of metabolic oxiran formation. , 1975, Biochemical pharmacology.

[9]  S. Nelson,et al.  Quantitative determination of the glutathione, cysteine, and N-acetyl cysteine conjugates of acetaminophen by high-pressure liquid chromatography. , 1977, Analytical biochemistry.

[10]  H. Driver,et al.  A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats. , 1983, Toxicology.

[11]  R. Kato,et al.  Reduction of tertiary amine N-oxides by liver microsomal cytochrome P-450. , 1976, Molecular pharmacology.

[12]  R. Hines,et al.  The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines. , 1980, The Journal of pharmacology and experimental therapeutics.

[13]  J. Hinson,et al.  N-Hydroxylation of phenacetin by hamster liver microsomes. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[14]  F. Guengerich,et al.  Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Ozols,et al.  The complete amino acid sequence of rabbit phenobarbital-induced liver microsomal cytochrome P-450. , 1983, The Journal of biological chemistry.

[16]  H. Bartsch,et al.  Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium , 1975, Nature.

[17]  H. Bolt,et al.  Covalent binding of haloethylenes. , 1981, Advances in experimental medicine and biology.

[18]  S. Orrenius,et al.  Effects of different cell constituents on metabolic activation and binding of benzo(a)pyrene to purified and nuclear DNA. , 1979, Biochemical and biophysical research communications.

[19]  E. Hodgson,et al.  Interaction of methylenedioxyphenyl (1,3-benzodioxole) compounds with enzymes and their effects on mammals. , 1974, Drug metabolism reviews (Softcover ed.).

[20]  Miller Re,et al.  Oxidation of trichloroethylene by liver microsomal cytochrome P-450: evidence for chlorine migration in a transition state not involving trichloroethylene oxide. , 1982 .

[21]  S. Nelson,et al.  Reduction and glutathione conjugation reactions of N-acetyl-p-benzoquinone imine and two dimethylated analogues. , 1984, Molecular pharmacology.

[22]  D. Griller,et al.  Free-radical clocks , 1980 .

[23]  T. Macdonald,et al.  Mechanisms of hydroxylation by cytochrome P-450: metabolism of monohalobenzenes by phenobarbital-induced microsomes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Mangold,et al.  The cytochrome P-450 active site. Regiospecificity of prosthetic heme alkylation by olefins and acetylenes. , 1983, The Journal of biological chemistry.

[25]  F. Guengerich Studies on the activation of a model furan compound--toxicity and covalent binding of 2-(N-ethylcarbamoylhydroxymethyl)furan. , 1977, Biochemical pharmacology.

[26]  I. White,et al.  Reaction of dihydropyrrolizines with deoxyribonucleic acids in vitro. , 1972, The Biochemical journal.

[27]  J. Idle,et al.  The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab population. , 1980, Xenobiotica; the fate of foreign compounds in biological systems.

[28]  L. Poulsen,et al.  The liver microsomal FAD-containing monooxygenase. Spectral characterization and kinetic studies. , 1979, The Journal of biological chemistry.

[29]  B. Masters Chapter 8 – The Role of NADPH-Cytochrome c (P-450) Reductase in Detoxication , 1980 .

[30]  F. Guengerich,et al.  Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. , 1984, Biochemistry.

[31]  B. Ketterer,et al.  The role of glutathione in detoxication , 1983, Environmental health perspectives.

[32]  F. Guengerich,et al.  Comparison of different forms of liver, kidney, and lung microsomal cytochrome P-450 by immunological inhibition of regio- and stereoselective metabolism of warfarin. , 1979, The Journal of biological chemistry.

[33]  L. J. Piper,et al.  The role of cytochrome P-450-inducing agents in potentiaing the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether). , 1980, Toxicology and applied pharmacology.

[34]  M. J. Coon,et al.  Interactions of cytochrome P-450, NADPH-cytochrome P-450 reductase, phospholipid, and substrate in the reconstituted liver microsomal enzyme system. , 1980, The Journal of biological chemistry.

[35]  L. Pohl,et al.  N-Hydroxyacetaminophen: a microsomal metabolite of N-hydroxyphenacetin but apparently not of acetaminophen. , 1979, Life sciences.

[36]  J. Swenberg,et al.  Cell-specific differences in O6-alkylguanine DNA repair activity during continuous exposure to carcinogen. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[37]  S. Orrenius,et al.  The role of methionine in glutathione biosynthesis by isolated hepatocytes. , 1977, Biochemical and biophysical research communications.

[38]  S. Orrenius,et al.  Bleb formation in hepatocytes during drug metabolism is caused by disturbances in thiol and calcium ion homeostasis. , 1982, Science.

[39]  S. Szabó,et al.  Hepatotoxicity of vinyl chloride and 1,1-dichloroethylene. Role of mixed function oxidase system. , 1975, The American journal of pathology.

[40]  C. Green,et al.  Metabolism, cytotoxicity, and genotoxicity of the pyrrolizidine alkaloid senecionine in primary cultures of rat hepatocytes. , 1981, Toxicology and applied pharmacology.

[41]  J. Mitchell,et al.  Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine. , 1977, Toxicology and applied pharmacology.

[42]  E. Johnson,et al.  Allosteric regulation of the 16 alpha-hydroxylation of progesterone as catalyzed by rabbit microsomal cytochrome P-450 3b. , 1983, The Journal of biological chemistry.

[43]  F. Guengerich,et al.  Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues. , 1982, Molecular pharmacology.

[44]  P. Moldéus,et al.  Prostaglandin synthetase catalyzed activation of paracetamol. , 1982, Biochemical pharmacology.

[45]  D. L. Cinti Agents activating the liver microsomal mixed function oxidase system , 1978 .

[46]  J. Allen,et al.  Synthesis of a tritium labelled pyrrolizidine alkaloidisenecioyl retronecine , 1975 .

[47]  P. Beaune,et al.  Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. , 1983, Biochemistry.

[48]  W. Jakoby,et al.  Cysteine conjugate beta-lyase. , 1983, Molecular pharmacology.

[49]  L. Moore,et al.  Inhibition of liver-microsome calcium pump by in vivo administration of CCl4, CHCl3 and 1,1-dichloroethylene (vinylidene chloride). , 1980, Biochemical pharmacology.

[50]  R. A. Neal,et al.  Toxicology of thiono-sulfur compounds. , 1982, Annual review of pharmacology and toxicology.

[51]  M. McKenna,et al.  The pharmacokinetics of [14C]vinylidene chloride in rats following inhalation exposure. , 1978, Toxicology and applied pharmacology.

[52]  P. Ortiz de Montellano,et al.  The catalytic mechanism of cytochrome P-450. Spin-trapping evidence for one-electron substrate oxidation. , 1982, The Journal of biological chemistry.

[53]  W. E. Fahl,et al.  Metabolism of benzo(a)pyrene by isolated hepatocytes and factors affecting covalent binding of benzo(a)pyrene metabolites to DNA in hepatocyte and microsomal systems. , 1980, Archives of biochemistry and biophysics.

[54]  L. Shuster,et al.  Cocaine-induced hepatic necrosis in mice--the role of cocaine metabolism. , 1979, Biochemical pharmacology.

[55]  N. Neff,et al.  Degradation of proteins microinjected into IMR-90 human diploid fibroblasts , 1981, The Journal of cell biology.

[56]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[57]  F. Kadlubar,et al.  Prostaglandin endoperoxide synthetase-mediated metabolism of carcinogenic aromatic amines and their binding to DNA and protein. , 1982, Biochemical and biophysical research communications.

[58]  F. Guengerich,et al.  Differences in the functional interaction of two purified cytochrome P-450 isozymes with epoxide hydrolase. , 1981, Journal of Biological Chemistry.

[59]  P. Thomas,et al.  Purification, characterization and regulation of five rat hepatic microsomal cytochrome P-450 isozymes. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[60]  H. Knapp,et al.  Energy-dependent calcium sequestration activity in rat liver microsomes. , 1975, The Journal of biological chemistry.

[61]  I. Calder,et al.  N-hydroxylation of p-acetophenetidide as a factor in nephrotoxicity. , 1973, Journal of medicinal chemistry.

[62]  F. Guengerich,et al.  Purification and characterization of liver microsomal cytochromes p-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or beta-naphthoflavone. , 1982, Biochemistry.

[63]  F. Guengerich,et al.  Destruction of highly purified cytochromes P-450 associated with metabolism of fluorinated ether anesthetics. , 1981, Archives of biochemistry and biophysics.

[64]  F. Guengerich Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. , 1977, The Journal of biological chemistry.

[65]  R. Jaeger,et al.  Effect of 18 hr fast and glutathione depletion on 1,1-dichloroethylene-induced hepatotoxicity and lethality in rats. , 1974, Experimental and molecular pathology.

[66]  A. Dipple,et al.  Selectivity in nucleoside alkylation and aralkylation in relation to chemical carcinogenesis , 1979 .

[67]  D. Warburton,et al.  Neural tube defects in spontaneous abortions. , 1986, American journal of medical genetics.

[68]  J. Bridges,et al.  The microsomal metabolism of the organometallic derivatives of the group-IV elements, germanium, tin and lead. , 1981, The Biochemical journal.

[69]  E. Lock,et al.  Role of microsomal and cytosolic glutathione S-transferases in the conjugation of hexachloro-1:3-butadiene and its possible relevance to toxicity. , 1984, The Journal of pharmacology and experimental therapeutics.

[70]  W. Stott,et al.  Roles of 2-haloethylene oxides and 2-haloacetaldehydes derived from vinyl bromide and vinyl chloride in irreversible binding to protein and DNA. , 1981, Cancer research.

[71]  J. P. Shea,et al.  MNDO calculation of kinetic isotope effects in model cytochrome P-450 oxidations , 1983 .

[72]  J. Groves,et al.  ON THE MECHANISM OF OXYGEN INSERTION CATALYZED BY CYTOCHROME P-450. HYDROXYLATION WITH PARTIAL ALLYLIC REARRANGEMENT , 1980 .

[73]  N. Ozawa,et al.  Evidence for formation of an S-[2-(N7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Pearson,et al.  Application of the Principle of Hard and Soft Acids and Bases to Organic Chemistry , 1967 .

[75]  J. Gillette,et al.  Studies on the mechanism of action of mammalian hepatic azoreductase. II. The effects of phenobarbital and 3-methylcholanthrene on carbon monoxide sensitive and insensitive azoreductase activities. , 1967, Biochemical pharmacology.

[76]  H. Gelboin,et al.  Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[77]  P. Moldéus,et al.  Metabolism of paracetamol to a glutathione conjugate catalyzed by prostaglandin synthetase. , 1980, Biochemical and biophysical research communications.

[78]  F. Guengerich,et al.  Glutathione-mediated binding of dibromoalkanes to DNA: specificity of rat glutathione-S-transferases and dibromoalkane structure. , 1984, Carcinogenesis.

[79]  T. Monks,et al.  Intra- and extra-cellular formation of metabolites from chemically reactive species. , 1984, Biochemical Society transactions.

[80]  M. Ihara,et al.  Novel synthesis of the pyrrolizidine skeleton by sulfenocycloamination. Total synthesis of (.+-.)-retronecine and (.+-.)-turneforcidine , 1983 .

[81]  J. Essigmann,et al.  Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[82]  T. C. Bruice Mechanisms of flavin catalysis , 1980 .

[83]  R. Kato,et al.  Studies on the mechanism of nitro reduction by rat liver. , 1969, Molecular pharmacology.

[84]  S. Thorgeirsson,et al.  Mechanism of N-hydroxy-2-acetylaminofluorene mutagenicity in the Salmonella test system. Role of N-O acyltransferase and sulfotransferase from rat liver. , 1981, Molecular Pharmacology.

[85]  A. Waiss,et al.  The Total Synthesis of (+)-Retronecine , 1962 .

[86]  L. Kaminsky,et al.  Fluroxene (2,2,2-trifluoroethyl vinyl ether) mediated destruction of cytochrome P-450 in vitro. , 1975, Biochemical pharmacology.

[87]  K. Robertson Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline. , 1982, Cancer research.

[88]  D. Hathway,et al.  The biological fate of vinylidene chloride in rats. , 1978, Chemico-biological interactions.

[89]  J. Ashby,et al.  Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus. , 1980, Carcinogenesis.

[90]  A. Y. Lu,et al.  Electroimmunochemical quantitation of cytochrome P-450, cytochrome P-448, and epoxide hydrolase in rat liver microsomes. , 1981, The Journal of biological chemistry.

[91]  F. Guengerich Preparation and properties of highly purified cytochrome p-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. , 1977, Molecular pharmacology.

[92]  G. L. Kedderis,et al.  The use of intramolecular isotope effects to distinguish between deprotonation and hydrogen atom abstraction mechanisms in cytochrome P-450- and peroxidase-catalyzed N-demethylation reactions. , 1983, The Journal of biological chemistry.

[93]  L. Prescott,et al.  Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. , 1971, Lancet.

[94]  L. Ernster,et al.  DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties. , 1962, Biochimica et biophysica acta.

[95]  A. Mattocks Pyrrolizidine alkaloid analogues. Part 2. Further hydroxymethyl-1-methyl-3-pyrrolines (synthanecines), and the preparation and esterification of some hydroxymethylpyrroles , 1978 .

[96]  A. Y. Lu,et al.  Studies on the stimulation of cytochrome P-450-dependent monooxygenase activity by dilauroylphosphatidylcholine. , 1981, Archives of biochemistry and biophysics.

[97]  C. Polnaszek,et al.  The kinetics of the aerobic reduction of nitrofurantoin by NADPH-cytochrome P-450 Ic) reductase. , 1981, Molecular pharmacology.

[98]  S. Orrenius,et al.  Regulation of intracellular calcium compartmentation: studies with isolated hepatocytes and t-butyl hydroperoxide. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[99]  F. Guengerich,et al.  Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine. , 1984, Cancer research.

[100]  D. Ballou,et al.  The reductive half-reaction of liver microsomal FAD-containing monooxygenase. , 1981, The Journal of biological chemistry.

[101]  F. Guengerich,et al.  Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. , 1982, Cancer research.

[102]  T. Kimura,et al.  Purification of mixed-function amine oxidase from rat liver microsomes. , 1983, Biochemical and biophysical research communications.

[103]  P. Thomas,et al.  Preparation of monospecific antibodies against two forms of rat liver cytochrome P-450 and quantitation of these antigens in microsomes. , 1979, Archives of biochemistry and biophysics.

[104]  H. Hauri,et al.  The turnover of cytochrome P450b , 1982, FEBS letters.

[105]  S. Nelson,et al.  Lack of evidence for N-hydroxyacetaminophen as a reactive metabolite of acetaminophen in vitro. , 1980, Biochemical pharmacology.

[106]  T. Orton,et al.  Cytochrome P-450 induction by clofibrate. Purification and properties of a hepatic cytochrome P-450 relatively specific for the 12- and 11-hydroxylation of dodecanoic acid (lauric acid). , 1982, The Biochemical journal.

[107]  B. Brodie,et al.  ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. III. CYTOCHROME P-450-MEDIATED COVALENT BINDING IN VITRO , 1973 .

[108]  J. Edgar,et al.  Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure. , 1976, Chemico-biological interactions.

[109]  L. Kaminsky,et al.  The role of cytochrome P-450 in the toxicity of fluroxene (2,2,2-trifluoroethyl vinyl ether) anaesthesia in vivo. , 1976, Biochemical pharmacology.

[110]  J. L. Seymour,et al.  Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione. , 1977, Cancer research.

[111]  T. Baillie,et al.  Comparative electron impact, chemical ionization and field desorption mass spectra of some thioether metabolites of acetaminophen. , 1981, Biomedical mass spectrometry.

[112]  F. Guengerich,et al.  Metabolism of trichloroethylene in isolated hepatocytes, microsomes, and reconstituted enzyme systems containing cytochrome P-450. , 1983, Cancer research.

[113]  S. Orrenius,et al.  Inhibition of ATP-dependent microsomal Ca2+ sequestration during oxidative stress and its prevention by glutathione. , 1983, The Journal of biological chemistry.

[114]  K. Hellmer,et al.  Binding of 14 C-carbon tetrachloride to microsomal proteins in vitro and formation of CHC1 3 by reduced liver microsomes. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[115]  F. Beland,et al.  Local carcinogenicity, rates of absorption, extent and persistence of macromolecular binding, and acute histopathological effects of N-hydroxy-1-naphthylamine and N-hydroxy-2-naphthylamine. , 1984, Cancer research.

[116]  T. Eling,et al.  Co-oxidation of benzidine by prostaglandin synthase and comparison with the action of horseradish peroxidase. , 1983, The Journal of biological chemistry.

[117]  J. P. Shea,et al.  Mechanism-based inactivation of cytochrome P-450 by heteroatom-substituted cyclopropanes and formation of ring-opened products , 1984 .

[118]  K. Ivanetich,et al.  Vinylidene chloride: its metabolism by hepatic microsomal cytochrome P-450 in vitro. , 1982, Biochemical pharmacology.

[119]  M. Huang,et al.  Studies on the mechanism of activation of microsomal benzo[a]pyrene hydroxylation by flavonoids. , 1981, The Journal of biological chemistry.

[120]  R Montesano,et al.  Mutagenic and carcinogenic N-nitroso compounds: possible environmental hazards. , 1976, Mutation research.

[121]  D. Liebler,et al.  Formation of glutathione conjugates by reactive metabolites of vinylidene chloride in microsomes and isolated hepatocytes. , 1985, Cancer research.

[122]  T. Sugimura,et al.  Mutagenicity of pyrrolizidine alkaloids in the Salmonella/mammalian-microsome test. , 1979, Mutation research.

[123]  J. Halpert,et al.  Covalent modification of lysine during the suicide inactivation of rat liver cytochrome P-450 by chloramphenicol. , 1981, Biochemical pharmacology.

[124]  G. Drummond,et al.  The cytochrome P-450-depleted animal: an experimental model for in vivo studies in chemical biology. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[125]  S. Nelson,et al.  Peroxidase-mediated formation of reactive metabolites of acetaminophen. , 1981, Molecular pharmacology.

[126]  R. Tullman,et al.  Suicidal inactivation of cytochrome P-450 by cyclopropylamines. Evidence for cation-radical intermediates , 1982 .

[127]  G. Kellermann,et al.  Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. , 1973, American journal of human genetics.

[128]  P. Thomas,et al.  The in vivo turnover of rat liver microsomal epoxide hydrolase and both the apoprotein and heme moieties of specific cytochrome P-450 isozymes. , 1983, Archives of biochemistry and biophysics.

[129]  A. Y. Lu,et al.  Drug residue formation from ronidazole, a 5-nitroimidazole. II. Involvement of microsomal NADPH-cytochrome P-450 reductase in protein alkylation in vitro. , 1982, Chemico-biological interactions.

[130]  L. Pohl,et al.  Reductive oxygenation of carbon tetrachloride: trichloromethylperoxyl radical as a possible intermediate in the conversion of carbon tetrachloride to electrophilic chlorine. , 1983, Archives of biochemistry and biophysics.

[131]  J. D. Vries Hepatotoxic metabolic activation of paracetamol and its derivatives phenacetin and benorilete: Oxygenation or electron transfer? , 1981 .

[132]  E C Miller,et al.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules , 1981, Cancer.

[133]  A. Y. Lu,et al.  Multiplicity of mammalian microsomal cytochromes P-45. , 1979, Pharmacological reviews.

[134]  P. Ortiz de Montellano,et al.  Stereochemistry of cytochrome P-450-catalyzed epoxidation and prosthetic heme alkylation. , 1983, The Journal of biological chemistry.

[135]  P. Smith Derivatives of hydrazine and other hydronitrogens having N-N bonds , 1983 .

[136]  F. Guengerich,et al.  3-Hydroxyacetaminophen: a microsomal metabolite of acetaminophen. Evidence against an epoxide as the reactive metabolite of acetaminophen. , 1980, Drug metabolism and disposition: the biological fate of chemicals.

[137]  J. Idle,et al.  The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions. , 1983, Journal of medical genetics.

[138]  R. A. Neal,et al.  Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. , 1983, Molecular pharmacology.

[139]  P. Ortiz de Montellano,et al.  Destruction of cytochrome P-450 by vinyl fluoride, fluroxene, and acetylene. Evidence for a radical intermediate in olefin oxidation. , 1982, Biochemistry.

[140]  R. Prough,et al.  Studies on the pathway of methane formation from procarbazine, a 2-methylbenzylhydrazine derivative, by rat liver microsomes. , 1983, Archives of biochemistry and biophysics.

[141]  J. Miller,et al.  Non-arene oxide aromatic ring hydroxylation of 2,2',5,5'-tetrachlorobiphenyl as the major metabolic pathway catalyzed by phenobarbital-induced rat liver microsomes. , 1983, The Journal of biological chemistry.

[142]  R. Kato,et al.  Evidence for the involvement of cytochrome P-450 in reduction of benzo(a)pyrene 4,5-oxide by rat liver microsomes. , 1976, Biochemical and biophysical research communications.

[143]  P. Watanabe,et al.  Activation of vinyl chloride to covalently bound metabolites: roles of 2-chloroethylene oxide and 2-chloroacetaldehyde. , 1979, Biochemistry.

[144]  J. Barrio,et al.  Etheno-substituted nucleotides and coenzymes: fluorescence and biological activity. , 1984, CRC critical reviews in biochemistry.

[145]  M. Correia,et al.  Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. , 1983, Annual review of pharmacology and toxicology.

[146]  J. Halpert,et al.  Suicide inactivation of rat liver cytochrome P-450 by chloramphenicol in vivo and in vitro. , 1983, Molecular pharmacology.

[147]  J. Idle,et al.  Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains , 1981, The Journal of pharmacy and pharmacology.

[148]  A. Conney,et al.  In vivo activation of zoxazolamine metabolism by flavone. , 1982, Science.

[149]  J. Wiseman,et al.  Mechanism of inhibition of horseradish peroxidase by cyclopropanone hydrate. , 1982, The Journal of biological chemistry.

[150]  F. Guengerich,et al.  Immunological comparison of rat, rabbit, and human liver NADPH-cytochrome P-450 reductases. , 1981, Biochemistry.

[151]  J. Miller,et al.  Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. , 1977, Cancer research.

[152]  C. Wolf,et al.  The rabbit pulmonary monooxygenase system: characteristics and activities of two forms of pulmonary cytochrome P-450. , 1978, Chemico-biological interactions.

[153]  J. Idle,et al.  Polymorphic sulphoxidation of S-carboxymethyl-L-cysteine in man. , 1982, Biochemical pharmacology.

[154]  T. Boyer,et al.  Acetaminophen-induced hepatic necrosis and renal failure. , 1971, JAMA.

[155]  M. Johnson,et al.  Studies on glutathione S-alkyltransferase of the rat. , 1966, The Biochemical journal.

[156]  J. Miller,et al.  In vivo combinations between carcinogens and tissue constituents and their possible role in carcinogenesis. , 1952, Cancer research.

[157]  D. Miner,et al.  Evidence for the involvement of N-acetyl-p- quinoneimine in acetaminophen metabolism. , 1979, Biochemical pharmacology.

[158]  C R Shaw,et al.  Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. , 1973, The New England journal of medicine.

[159]  G. Williams,et al.  Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[160]  C. Miranda,et al.  Effect of pyrrolizidine alkaloids from tansy ragwort (senecio jacobaea) on hepatic drug-metabolizing enzymes in male rats. , 1980, Biochemical pharmacology.

[161]  D. Ziegler Chapter 9 – Microsomal Flavin-Containing Monooxygenase: Oxygenation of Nucleophilic Nitrogen and Sulfur Compounds , 1980 .

[162]  R. Schoental Pancreatic islet-cell and other tumors in rats given heliotrine, a monoester pyrrolizidine alkaloid, and nicotinamide. , 1975, Cancer research.

[163]  S. Nelson,et al.  Synthesis, decomposition kinetics, and preliminary toxicological studies of pure N-acetyl-p-benzoquinone imine, a proposed toxic metabolite of acetaminophen. , 1982, Journal of medicinal chemistry.

[164]  K. Sharpless,et al.  Chromyl chloride oxidations of olefins. Possible role of organometallic intermediates in the oxidations of olefins by oxo transition metal species , 1977 .

[165]  R. Jaeger,et al.  1,1-Dichloroethylene hepatotoxicity. Time course of GSH changes and biochemical aberrations. , 1980, The American journal of pathology.

[166]  D. Labadarios,et al.  Paracetamol-induced hepatic necrosis in the mouse-relationship between covalent binding, hepatic glutathione depletion and the protective effect of alpha-mercaptopropionylglycine. , 1977, Biochemical pharmacology.

[167]  J. Miller,et al.  Microsomal N-oxidation of the hepatocarcinogen N-methyl-4-aminoazobenzene and the reactivity of N-hydroxy-N-methyl-4-aminoazobenzene. , 1976, Cancer research.

[168]  T. Baillie,et al.  The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. , 1984, Chemico-biological interactions.

[169]  Macdonald Tl Chemical mechanisms of halocarbon metabolism , 1983 .

[170]  L. Endrenyi,et al.  Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and Orientals. , 1980, Canadian Journal of Physiology and Pharmacology.

[171]  J. Idle,et al.  POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN , 1977, The Lancet.

[172]  M. Murphy,et al.  Acute toxicity of fluorinated ether anesthetics: role of 2,2,2-trifluoroethanol and other metabolites. , 1983, Toxicology and applied pharmacology.

[173]  A. Mattocks Relation of structural features to pyrrolic metabolites in livers of rats given pyrrolizidine alkaloids and derivatives. , 1981, Chemico-biological interactions.

[174]  B B Brodie,et al.  Possible mechanism of liver necrosis caused by aromatic organic compounds. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[175]  D. J. Reed,et al.  Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). , 1983, Biochemical pharmacology.

[176]  M. J. Coon,et al.  Complete amino acid sequence and predicted membrane topology of phenobarbital-induced cytochrome P-450 (isozyme 2) from rabbit liver microsomes. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[177]  A. H. Phillips,et al.  Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. , 1962, The Journal of biological chemistry.

[178]  I. Bird,et al.  Alkylation by dehydroretronecine, a cytotoxic metabolite of some pyrrolizidine alkaloids: an in vitro test. , 1983, Toxicology letters.

[179]  H. A. Masson,et al.  Metabolic activation of paracetamol by highly purified forms of cytochrome P-450. , 1983, Research communications in chemical pathology and pharmacology.

[180]  F. Guengerich,et al.  Aryl hydrocarbon hydroxylase is inhibited by antibody to rat liver cytochrome P-450. , 1980, Science.

[181]  V. Ullrich,et al.  Separation and purification of liver microsomal monooxygenases from induced and untreated pigs. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[182]  M. Burke Cytochrome P-450: a pharmacological necessity or a biochemical curiosity? , 1981, Biochemical pharmacology.

[183]  E. Miller,et al.  The Presence and Significance of Bound Aminoazo Dyes in the Livers of Rats Fed p-Dimethylaminoazobenzene , 1947 .

[184]  R. A. Neal,et al.  Identification of the major protein adduct formed in rat liver after thioacetamide administration. , 1981, Cancer research.

[185]  G. Divincenzo,et al.  The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. , 1980, Toxicology and applied pharmacology.

[186]  Y. Vaishnav,et al.  Evidence that acetaminophen and N-hydroxyacetaminophen form a common arylating intermediate, N-acetyl-p-benzoquinoneimine. , 1980, Molecular pharmacology.

[187]  Guengerich Fp,et al.  Olefin oxidation by cytochrome P-450: evidence for group migration in catalytic intermediates formed with vinylidene chloride and trans-1-phenyl-1-butene. , 1983 .

[188]  M. J. Coon,et al.  19 P-450 Oxygenases in Lipid Transformation , 1983 .

[189]  Y. Yasukochi,et al.  The omega- and (omega-1)-hydroxylase activities of prostaglandins A1 and E1 and lauric acid by pig kidney microsomes and a purified kidney cytochrome P-450. , 1981, The Journal of biological chemistry.

[190]  L. J. Jenkins,et al.  Biochemical effects of 1,1-dichloroethylene in rats: comparison with carbon tetrachloride and 1,2-dichloroethylene. , 1972, Toxicology and applied pharmacology.

[191]  F C Kauffman,et al.  Factors regulating drug metabolism in intact hepatocytes. , 1979, Pharmacological reviews.

[192]  F. Guengerich,et al.  Interaction of liver microsomal cytochrome P-450 and NADPH-cytochrome P-450 reductase in the presence and absence of lipid. , 1984, The Journal of biological chemistry.

[193]  E. Bresnick Chapter 4 – Induction of the Enzymes of Detoxication , 1980 .

[194]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[195]  E. Mimnaugh,et al.  Lung-selective impairment of cytochrome P-450-dependent monooxygenases and cellular injury by 1,1-dichloroethylene in mice. , 1983, Biochemical and biophysical research communications.

[196]  E. Cadenas,et al.  CHAPTER 7 – Biological Basis of Detoxication of Oxygen Free Radicals* , 1983 .

[197]  F. Guengerich,et al.  Mechanism of cytochrome P-450 inhibition by cyclopropylamines , 1982 .

[198]  A. Y. Lu,et al.  N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[199]  F. Guengerich,et al.  Chemical mechanisms of catalysis by cytochromes P-450: a unified view , 1984 .

[200]  M. R. Boyd,et al.  Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. , 1980, Critical reviews in toxicology.

[201]  A. Conney,et al.  Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids. , 1981, Cancer research.

[202]  R. Hines,et al.  The oxidation of hydrazine derivatives catalyzed by the purified liver microsomal FAD-containing monooxygenase. , 1981, The Journal of biological chemistry.

[203]  J. W. Frost,et al.  Flavoprotein monooxygenases: A chemical model , 1981 .

[204]  M. Boyd,et al.  The effect of hepatic metabolism on the production and toxicity of reactive metabolites in extrahepatic organs. , 1983, Drug metabolism reviews.

[205]  V. McKusick,et al.  Genetic Control of Isoniazid Metabolism in Man , 1960, British medical journal.

[206]  G. Mudge,et al.  Covalent binding of metabolites of acetaminophen to kidney protein and depletion of renal glutathione. , 1978, The Journal of pharmacology and experimental therapeutics.

[207]  M. Andersen,et al.  1,1-Dichloroethylene nephrotoxicity in the rat. , 1978, Toxicology and applied pharmacology.

[208]  F. Guengerich,et al.  Regulation of cytochrome P-450. Immunochemical quantitation of eight isozymes in liver microsomes of rats treated with polybrominated biphenyl congeners. , 1983, The Journal of biological chemistry.

[209]  F. Guengerich Effects of nutritive factors on metabolic processes involving bioactivation and detoxication of chemicals. , 1984, Annual review of nutrition.

[210]  D. Mansuy,et al.  N-substituted porphyrins formation from carbene iron-porphyrin complexes: a possible pathway for cytochrome P450 heme destruction. , 1981 .

[211]  I. Bird,et al.  Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity. , 1983, Chemico-biological interactions.

[212]  J. Halpert Further studies of the suicide inactivation of purified rat liver cytochrome P-450 by chloramphenicol. , 1982, Molecular pharmacology.

[213]  D. Jollow,et al.  Microsomal N-Hydroxylation of p-Chloroacetanilide , 1975 .

[214]  M. Watanabe,et al.  Purification and characterization of pulmonary cytochrome P-450 from 3-methylcholanthrene-treated rats. , 1983, Journal of biochemistry.

[215]  M. J. Coon,et al.  Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. , 1983, Biochemical and biophysical research communications.

[216]  H. Strobel,et al.  Multiple forms of cytochrome P-450 in liver microsomes from beta-naphthoflavone-pretreated rats. Separation, purification, and characterization of five forms. , 1982, The Journal of biological chemistry.

[217]  M. Boyd,et al.  In vivo studies on the relationship between target organ alkylation and the pulmonary toxicity of a chemically reactive metabolite of 4-ipomeanol. , 1978, The Journal of pharmacology and experimental therapeutics.

[218]  R. V. Van dyke,et al.  Anaerobic release of fluoride from halothane. Relationship to the binding of halothane metabolites to hepatic cellular constituents. , 1976, Drug metabolism and disposition: the biological fate of chemicals.

[219]  E. M. Boyd,et al.  Liver necrosis from paracetamol. , 1966, British journal of pharmacology and chemotherapy.

[220]  G. Williams,et al.  Genotoxicity of pyrrolizidine alkaloids in the hepatocyte primary culture/DNA-repair test. , 1980, Mutation research.

[221]  F. Guengerich,et al.  Isolation and purification of cytochrome P-450, and the existence of multiple forms. , 1979, Pharmacology & therapeutics.

[222]  F. Guengerich,et al.  Purification and characterization of microsomal cytochrome P-450s. , 1982, Xenobiotica; the fate of foreign compounds in biological systems.

[223]  M. Metzler,et al.  Reactions of trichloroethylene epoxide in aqueous systems. , 1979, Biochemical pharmacology.

[224]  D. Nebert Chapter 3 – Human Genetic Variation in the Enzymes of Detoxication , 1980 .

[225]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. , 1973, The Journal of pharmacology and experimental therapeutics.

[226]  A. Boobis,et al.  Paracetamol oxidation: synthesis and reactivity of N-acetyl-p-benzoquinoneimine , 1981 .

[227]  J. Idle,et al.  Polymorphisms of oxidation at carbon centers of drugs and their clinical significance. , 1979, Drug metabolism reviews.

[228]  A. Y. Lu,et al.  Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. , 1976, The Journal of biological chemistry.

[229]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. , 1973, The Journal of pharmacology and experimental therapeutics.

[230]  A. Mattocks Synthetic Compounds with Toxic Properties similar to those of Pyrrolizidine Alkaloids and their Pyrrolic Metabolites , 1971, Nature.

[231]  F. Guengerich,et al.  Interaction of epoxide hydrolase with itself and other microsomal proteins. , 1982, Archives of biochemistry and biophysics.

[232]  M. Ziman,et al.  Organic compounds. Their interaction with and degradation of hepatic microsomal drug-metabolizing enzymes in vitro. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[233]  D. Kingston,et al.  Structure elucidation of a potent mutagen from human feces , 1982 .

[234]  D. Blake,et al.  Animal toxicity of 2,2,2-trifluoroethanol. , 1969, Toxicology and applied pharmacology.

[235]  K. Ham,et al.  N-hydroxyacetaminophen: a postulated toxic metabolite of acetaminophen. , 1981, Journal of medicinal chemistry.

[236]  D. Mansuy,et al.  Oxidation of monosubstituted olefins by cytochromes P-450 and heme models: evidence for the formation of aldehydes in addition to epoxides and allylic alcohols. , 1984, Biochemical and biophysical research communications.

[237]  J. Gillette The use of theoretical pharmacokinetic concepts in studies of the mechanisms of formation of chemically reactive metabolites in vitro and in vivo. , 1983, Drug metabolism reviews.

[238]  Guengerich Fp Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems , 1983 .

[239]  Guengerich Fp,et al.  In Vitro Metabolism of Acrylonitrile to 2-Cyanoethylene Oxide, Reaction with Glutathione, and Irreversible Binding to Proteins and Nucleic Acids , 1981 .

[240]  R. Prough,et al.  Butylated hydroxyanisole-stimulated NADPH oxidase activity in rat liver microsomal fractions. , 1983, The Journal of biological chemistry.

[241]  D. Pfeiffer,et al.  The role of glutathione in the retention of Ca2+ by liver mitochondria. , 1984, The Journal of biological chemistry.

[242]  K. Netter Inhibition of oxidative drug metabolism in microsomes. , 1980, Pharmacology & therapeutics.

[243]  F. Guengerich,et al.  An immunohistochemical study on the localization and distributions of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 within the livers of untreated rats. , 1981, The Journal of biological chemistry.

[244]  R. Preisig,et al.  Inherited Defects of Hepatic Drug Metabolism , 1983, Seminars in liver disease.

[245]  W. Nastainczyk,et al.  The mechanism of reductive dehalogenation of halothane by liver cytochrome P450. , 1982, Biochemical pharmacology.

[246]  I. D. Spenser The biosynthesis of retronecine , 1982 .

[247]  T. Monks,et al.  3-(glutathion-S-yl)acetaminophen: a biliary metabolite of acetaminophen. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[248]  P. Ortiz de Montellano,et al.  Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Isolation of an NN-bridged benzyne-protoporphyrin IX adduct. , 1981, The Biochemical journal.

[249]  A. Pegg,et al.  Alkylation of intracellular and extracellular DNA by dimethylnitrosamine following activation by isolated rat hepatocytes. , 1981, Cancer research.

[250]  C. Culvenor Tumor-inhibitory activity of pyrrolizidine alkaloids. , 1968, Journal of pharmaceutical sciences.

[251]  S. Orrenius,et al.  Biotransformation of bromobenzene to reactive metabolites by isolated hepatocytes. , 1981, Advances in experimental medicine and biology.

[252]  C. Walsh Flavin coenzymes: at the crossroads of biological redox chemistry , 1980 .

[253]  J. Groves,et al.  Catalytic asymmetric epoxidations with chiral iron porphyrins , 1983 .

[254]  F. Guengerich,et al.  Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.

[255]  F. Guengerich,et al.  Metabolism of vinyl chloride: destruction of the heme of highly purified liver Microsomal cytochrome P-450 by a metabolite. , 1977, Molecular pharmacology.

[256]  D. Jerina,et al.  Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[257]  Y. Fujii‐Kuriyama,et al.  Primary structure of a cytochrome P-450: coding nucleotide sequence of phenobarbital-inducible cytochrome P-450 cDNA from rat liver. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[258]  G. Duggin,et al.  Metabolic oxidation of acetaminophen (paracetamol) mediated by cytochrome P-450 mixed-function oxidase and prostaglandin endoperoxide synthetase in rabbit kidney. , 1981, Toxicology and applied pharmacology.

[259]  I. White,et al.  The conversion of pyrrolizidine alkaloids to N-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in vitro. , 1971, Chemico-biological interactions.

[260]  D. Jerina,et al.  Mechanism of the inhibition of mutagenicity of a benzo[a]pyrene 7,8-diol 9,10-epoxide by riboflavin 5'-phosphate. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[261]  L. Flohé,et al.  Oxidation in the NADP system and release of GSSG from hemoglobin‐free perfused rat liver during peroxidatic oxidation of glutathione by hydroperoxides , 1972, FEBS letters.

[262]  T. Omura,et al.  Turnover of two drug-inducible forms of microsomal cytochrome P-450 in rat liver. , 1983, Journal of biochemistry.

[263]  A. Y. Lu,et al.  Chapter 7 – Reactions Catalyzed by the Cytochrome P-450 System , 1980 .

[264]  S. Nelson,et al.  Metabolic activation and drug toxicity. , 1982, Journal of medicinal chemistry.

[265]  R. A. Neal,et al.  Inactivation of purified rat liver cytochrome P-450 during the metabolism of parathion (diethyl p-nitrophenyl phosphorothionate). , 1980, The Journal of biological chemistry.

[266]  C. Kasper,et al.  Chapter 1 – Glucuronidation , 1980 .

[267]  T. Ishikawa,et al.  Cardiac transport of glutathione disulfide and S-conjugate. Studies with isolated perfused rat heart during hydroperoxide metabolism. , 1984, The Journal of biological chemistry.

[268]  P. Watanabe,et al.  In vitro activation of 1,2-dichloroethane by microsomal and cytosolic enzymes. , 1980, Toxicology and applied pharmacology.

[269]  A. Mclean,et al.  Dissociation of cell death from covalent binding of paracetamol by flavones in a hepatocyte system. , 1982, Biochemical pharmacology.

[270]  K. Steenland,et al.  Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes. , 1981, Cancer research.

[271]  K. Ham,et al.  Studies on the mechanism of toxicity of acetaminophen. Synthesis and reactions of N-acetyl-2,6-dimethyl- and N-acetyl-3,5-dimethyl-p-benzoquinone imines. , 1980, Journal of medicinal chemistry.

[272]  B. Saville The Concept of Hard and Soft Acids and Bases as Applied to Multi‐Center Chemical Reactions , 1967 .

[273]  T. Wolff,et al.  Formation of irreversible protein-binding metabolites during microsomal metabolism of 14C-bromobenzene and 14C-bromophenol. , 1981, Advances in experimental medicine and biology.

[274]  D. Griller,et al.  Electron paramagnetic resonance and the art of physical-organic chemistry , 1980 .

[275]  E. Reynolds,et al.  Massive hepatic necrosis after fluroxene anesthesia--a case of drug interaction? , 1972, The New England journal of medicine.

[276]  R. Silverman Mechanism of inactivation of monoamine oxidase by trans-2-phenylcyclopropylamine and the structure of the enzyme-inactivator adduct. , 1983, The Journal of biological chemistry.

[277]  E Dybing,et al.  Cytotoxic effects of N-acetyl-p-benzoquinone imine, a common arylating intermediate of paracetamol and N-hydroxyparacetamol. , 1984, Biochemical pharmacology.

[278]  T. Ho Hard and Soft Acids and Bases Principle in Organic Chemistry , 1977 .

[279]  Ritchie Jc Population studies of polymorphism in drug oxidation and its relevance to carcinogenesis. , 1982 .

[280]  B B Brodie,et al.  Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. , 1973, The Journal of pharmacology and experimental therapeutics.

[281]  H. Segall,et al.  A new pyrrolizidine alkaloid metabolite, 19-hydroxysenecionine isolated from mouse hepatic microsomes in vitro. , 1982, Drug metabolism and disposition: the biological fate of chemicals.

[282]  F. Guengerich,et al.  Metabolism of acrylonitrile by isolated rat hepatocytes. , 1983, Cancer research.

[283]  W. Anderson Activity of bis-carbamoyloxymethyl derivatives of pyrroles and pyrrolizines against human tumor xenografts in nude mice. , 1982, Cancer research.

[284]  S. Orrenius,et al.  The metabolism of menadione (2-methyl-1,4-naphthoquinone) by isolated hepatocytes. A study of the implications of oxidative stress in intact cells. , 1982, The Journal of biological chemistry.

[285]  T. Kamataki,et al.  Activation and detoxication of N-hydroxy-Trp-P-2 by glutathione and glutathione transferases. , 1983, Carcinogenesis.

[286]  J. Graham,et al.  Changes in dimethylaniline N-oxidase activity of mouse liver and kidney induced by steroid sex hormones. , 1981, Molecular pharmacology.